Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
- PMID: 9334342
- PMCID: PMC2139791
- DOI: 10.1083/jcb.139.2.375
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
Abstract
Genetic defects in a number of components of the dystrophin-glycoprotein complex (DGC) lead to distinct forms of muscular dystrophy. However, little is known about how alterations in the DGC are manifested in the pathophysiology present in dystrophic muscle tissue. One hypothesis is that the DGC protects the sarcolemma from contraction-induced damage. Using tracer molecules, we compared sarcolemmal integrity in animal models for muscular dystrophy and in muscular dystrophy patient samples. Evans blue, a low molecular weight diazo dye, does not cross into skeletal muscle fibers in normal mice. In contrast, mdx mice, a dystrophin-deficient animal model for Duchenne muscular dystrophy, showed significant Evans blue accumulation in skeletal muscle fibers. We also studied Evans blue dispersion in transgenic mice bearing different dystrophin mutations, and we demonstrated that cytoskeletal and sarcolemmal attachment of dystrophin might be a necessary requirement to prevent serious fiber damage. The extent of dye incorporation in transgenic mice correlated with the phenotypic severity of similar dystrophin mutations in humans. We furthermore assessed Evans blue incorporation in skeletal muscle of the dystrophia muscularis (dy/dy) mouse and its milder allelic variant, the dy2J/dy2J mouse, animal models for congenital muscular dystrophy. Surprisingly, these mice, which have defects in the laminin alpha2-chain, an extracellular ligand of the DGC, showed little Evans blue accumulation in their skeletal muscles. Taken together, these results suggest that the pathogenic mechanisms in congenital muscular dystrophy are different from those in Duchenne muscular dystrophy, although the primary defects originate in two components associated with the same protein complex.
Figures









Similar articles
-
Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.Am J Pathol. 2014 Mar;184(3):740-52. doi: 10.1016/j.ajpath.2013.11.017. Epub 2014 Jan 4. Am J Pathol. 2014. PMID: 24393714
-
Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.Muscle Nerve. 2008 Jan;37(1):61-7. doi: 10.1002/mus.20892. Muscle Nerve. 2008. PMID: 17724738
-
The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability.J Child Neurol. 1995 Mar;10(2):150-9. doi: 10.1177/088307389501000219. J Child Neurol. 1995. PMID: 7782608 Review.
-
Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.J Cell Biol. 2001 Mar 19;152(6):1207-18. doi: 10.1083/jcb.152.6.1207. J Cell Biol. 2001. PMID: 11257121 Free PMC article.
-
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.Biomed Res Int. 2015;2015:635792. doi: 10.1155/2015/635792. Epub 2015 Aug 24. Biomed Res Int. 2015. PMID: 26380289 Free PMC article. Review.
Cited by
-
Wnt7a treatment ameliorates muscular dystrophy.Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20614-9. doi: 10.1073/pnas.1215765109. Epub 2012 Nov 26. Proc Natl Acad Sci U S A. 2012. PMID: 23185011 Free PMC article.
-
High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD.Hum Mol Genet. 2016 Dec 15;25(24):5395-5406. doi: 10.1093/hmg/ddw356. Hum Mol Genet. 2016. PMID: 27798107 Free PMC article.
-
Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle.Hum Mol Genet. 2019 Apr 1;28(7):1117-1135. doi: 10.1093/hmg/ddy418. Hum Mol Genet. 2019. PMID: 30535187 Free PMC article.
-
Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice.Am J Pathol. 2006 Dec;169(6):2148-60. doi: 10.2353/ajpath.2006.060570. Am J Pathol. 2006. PMID: 17148677 Free PMC article.
-
Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress.Cells. 2019 Jan 15;8(1):53. doi: 10.3390/cells8010053. Cells. 2019. PMID: 30650618 Free PMC article.
References
-
- Allamand V, Sunada Y, Salih MAM, Straub V, Ozo CO, Al-Turaike MHS, Akbar M, Kolo T, Collognato H, Zhang X, et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain. Hum Mol Genet. 1997;6:747–752. - PubMed
-
- Bell CD, Conen PE. Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci. 1968;7:529–544. - PubMed
-
- Bodensteiner JB, Engel AG. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology. 1978;28:439–446. - PubMed
-
- Bradley WG, Fulthorpe JJ. Studies of sarcolemmal integrity in myopathic muscle. Neurology. 1978;28:670–677. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases